Temozolomide All-Case-Registered Surveillance (Designated Drug Use Investigation)(Study P05062)

This study is enrolling participants by invitation only.
Sponsor:
Information provided by:
Merck
ClinicalTrials.gov Identifier:
NCT00705198
First received: June 23, 2008
Last updated: October 24, 2012
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: October 2016
  Estimated Primary Completion Date: October 2016 (Final data collection date for primary outcome measure)